HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean Christophe Ouallet Selected Research

Multiple Sclerosis

8/2015Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean Christophe Ouallet Research Topics

Disease

1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2021
1Inflammation (Inflammations)
01/2021
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021
1Neuromyelitis Optica (Devic's Disease)
10/2015
1Multiple Sclerosis
08/2015
1Femoral Neuropathy
07/2015

Drug/Important Bio-Agent (IBA)

1GadoliniumIBA
01/2021
1SteroidsIBA
01/2021
1Rituximab (Mabthera)FDA Link
10/2015
1InterferonsIBA
08/2015
1Glatiramer Acetate (Copaxone)FDA Link
07/2015

Therapy/Procedure

1Therapeutics
10/2015
1Subcutaneous Injections
07/2015